[1]
Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol 2008; 26(11): 1261-8.
[2]
Tamjidi F, Shahedia M, Varshosazb J, Nasirpoura A. Nanostructured lipid carriers (NLC): A potential delivery system for bioactive food molecules. Innov Food Sci Emerg Technol 2103(19): 29-43.
[3]
Rahman M, Kumar V, Beg S, Sharma G, Katare OP, Anwar F. Emergence of liposome as targeted magic bullet for inflammatory disorders: current state of the art. Artif Cells Nanomed Biotechnol 2016; 44(7): 1597-608.
[4]
Kim BS, Won M, Lee KM, Kim CS. In vitro permeation studies of nanoemulsions containing ketoprofen as a model drug. Drug Deliv 2008; 15(7): 465-9.
[5]
Kale SN, Deore SL. Emulsion, micro-emulsion and nano emulsion. Sys Rev Pharm 2017; 8(1): 39-47.
[6]
Abd E, Benson HAE, Roberts MS, Grice JE. Minoxidil skin delivery from nanoemulsion formulations containing eucalyptol or oleic acid: enhanced diffusivity and follicular targeting. Pharmaceutics 2018; 10(1): 19.
[7]
Schroeter A, Engelbrecht T, Neubert RH, Goebel AS. New nanosized technologies for dermal and transdermal drug delivery. A review. J Biomed Nanotechnol 2010; 6(5): 511-28.
[8]
Kogan A, Garti N. Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci 2006; 123-126: 369-85.
[9]
Rahman M, Akhter S, Ahmad J, Ahmad MZ, Beg S, Ahmad FJ. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy. Expert Opin Drug Deliv 2015; 12(4): 635-52.
[10]
Barry BW. Breaching the skin’s barrier to drugs. Nat Biotechnol 2004; 22(2): 165-7.
[11]
Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv 2010; 1(1): 109-31.
[12]
O López, M Cócera, Wertz PW, López-Iglesias C, de la Maza A. New arrangement of proteins and lipids in the stratum corneum cornified envelope. Biochim Biophys Acta Biomembr 2007; 1768(3): 521-9.
[13]
Panwar N. Upadhyay, M Bairagi, S Gujar, G Darwhekar emulgel. A review. Asian J Pharm Life Sci 2011; 1(3): 333-43.
[14]
Bandyopadhyay S, Katare OP, Singh B. Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides. Colloids Surf B Biointerfaces 2012; 100: 50-61.
[15]
Singh Y, Meher JG, Raval K, Khan FA, Chaurasia M, Jain NK, et al. Nanoemulsion: Concepts, development and applications in drug delivery. J Control Release 2017; 252: 28-49.
[16]
Calder PC. Hot topics in parenteral nutrition. Rationale for using new lipid emulsions in parenteral nutrition and a review of the trials performed in adults. Proc Nutr Soc 2009; 68(3): 252-60.
[17]
Manuel-y-Keenoy B, Nonneman L, De Bosscher H, Vertommen J, Schrans S, Klütsch K, et al. Effects of intravenous supplementation with alpha-tocopherol in patients receiving total parenteral nutrition containing medium- and long-chain triglycerides. Eur J Clin Nutr 2002; 56(2): 121-8.
[18]
Hippalgaonkar K, Majumdar S, Kansara V. Injectable lipid emulsions-advancements, opportunities and challenges. AAPS PharmSciTech 2010; 11(4): 1526-40.
[19]
Choudhury H, Gorain B, Karmakar S, Biswas E, Dey G, Barik R, et al. Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform. Int J Pharm 2014; 460(1-2): 131-43.
[20]
Derle D, Sagar B, Sagar P. Microemulsion as a vehicle for transdermal permeation of nimesulide. Indian J Pharm Sci 2006; 68(5): 622-5.
[21]
Pawar KR, Babu RJ. Lipid materials for topical and transdermal delivery of nanoemulsions. Crit Rev Ther Drug Carrier Syst 2014; 31(5): 429-58.
[22]
Nastiti CMRR, Ponto T, Abd E, Grice JE, Benson HAE, Roberts MS. Topical nano and microemulsions for skin delivery. Pharmaceutics 2017; 9(4)9040037
[23]
Lee SY, Pung YY, Khor BK, Kong WE, Tan CT, Teo SY. Lipid-based delivery system for topical phenytoin. J Appl Pharm Sci 2016; 6(11): 14-20.
[24]
Dhawan B, Aggarwal G, Harikumar S. Enhanced transdermal permeability of piroxicam through novel nanoemulgel formulation. Int J Pharm Investig 2014; 4(2): 65-76.
[26]
Deapsari, Erawati TM, Soeratri W. Penetration of ubiquinone (Q10) nanoemulsion using olive oil through rat skin. Int J Pharm Clin Res 2017; 9(2): 169-72.
[27]
Scholfield CR. Composition of soybean lecithin. Reprinted from. J Am Oil Chem Soc 1981; 58(10): 889-92.
[28]
van Hoogevest P, Wendel A. The use of natural and synthetic phospholipids as pharmaceutical excipients. Eur J Lipid Sci Technol 2014; 116(9): 1088-107.
[29]
Kato A, Ishibashi Y, Miyake Y. Effect of egg yolk lecithin on transdermal delivery of bunazosin hydrochloride. J Pharm Pharmacol 1987; 39(5): 399-400.
[30]
Hoeller S, Sperger A, Valenta C. Lecithin based nanoemulsions: A comparative study of the influence of non-ionic surfactants and the cationic phytosphingosine on physicochemical behaviour and skin permeation. Int J Pharm 2009; 370(1-2): 181-6.
[31]
Wu H, Ramachandran C, Weiner ND, Roessler BJ. Topical transport of hydrophilic compounds using water-in-oil nanoemulsions. Int J Pharm 2001; 220(1-2): 63-75.
[32]
Barry BW. Lipid-protein-partitioning theory of skin penetration enhancement. J Control Release 1991; 15(3): 237-48.
[33]
Lopes LB, VanDeWall H, Li HT, Venugopal V, Li HK, Naydin S, et al. Topical delivery of lycopene using microemulsions: enhanced skin penetration and tissue antioxidant activity. J Pharm Sci 2010; 99(3): 1346-57.
[34]
Khani S, Keyhanfar F, Amani A. Design and evaluation of oral nanoemulsion drug delivery system of mebudipine. Drug Deliv 2016; 23(6): 2035-43.
[36]
Pund S, Pawar S, Gangurde S, Divate D. Transcutaneous delivery of leflunomide nanoemulgel: Mechanistic investigation into physicomechanical characteristics, in vitro anti-psoriatic and anti-melanoma activity. Int J Pharm 2015; 487(1-2): 148-56.
[37]
Radhika PR, Guruprasad S. Nanoemulsion based emulgel formulation of lipophilic drug for topical delivery. Int J Pharm Tech Res 2016; 9(6): 210-23.
[38]
Sonal S. Appraisal of transdermal water-in-oil nanoemulgel of selegiline HCl for the effective management of parkinson’s disease: pharmacodynamic, pharmacokinetic, and biochemical investigations. AAPS PharmSciTech 2018; 19(2): 573-89.
[39]
Hauss DJ. Oral lipid-based formulations. Adv Drug Deliv Rev 2007; 59(7): 667-76.
[40]
Mortazavi S, Aboofazeli R. An investigation into the effect of various penetration enhancers on percutaneous absorption of piroxicam. Iran J Pharm Res 2003; 2: 135-40.
[41]
Pathan IB, Setty CM. Chemical penetration enhancers for transdermal drug delivery systems. Trop J Pharm Res 2009; 8(2): 173-9.
[42]
Srivastava M, Kohli K, Ali M. Formulation development of novel in situ nanoemulgel (NEG) of ketoprofen for the treatment of periodontitis. Drug Deliv 2016; 23(1): 154-66.
[43]
Ernoviya E, Masfria M, Sinaga KR, et al. Optimization and evaluation of topical ketoconazole nanoemulsion. Asian J Pharm Clin Res 2018; 11(5): 143-6.
[44]
Solè I, Maestro A, Gonzalez C, Solans C, Gutiérrez JM. Optimization of nano-emulsion preparation by low-energy methods in an ionic surfactant system. Langmuir 2006; 22(20): 8326-32.
[45]
Mason TG, Graves SM, Wilking JN, Lin MY. Extreme emulsification: Formation and structure of nanoemulsions. J Phys Condens Matter 2006; 9(1): 193-9.
[46]
Graves S, Meleson K, Wilking J, Lin MY, Mason TG. Structure of concentrated nanoemulsions. J Chem Phys 2005; 122(13)134703
[47]
Peng Jie, Dong Wu-jun, Li Ling, Xu JM, Jin DJ, Xia XJ, et al. Effect of high-pressure homogenization preparation on mean globule size and large diameter tail of oil-in-water injectable emulsions. J Food Drug Analysis 2015; 23: 828-35.
[48]
Kotta S, Khan AW, Ansari SH, Sharma RK, Ali J. Formulation of nanoemulsion: A comparison between phase inversion composition method and high-pressure homogenization method. Drug Deliv 2015; 22(4): 455-66.
[49]
Lovelyn C, Attama AA. Current state of nanoemulsions in drug delivery. J Biomater Nanobiotechnol 2011; 2: 626-39.
[50]
Leong TS, Wooster TJ, Kentish SE, Ashokkumar M. Minimising oil droplet size using ultrasonic emulsification. Ultrason Sonochem 2009; 16(6): 721-7.
[51]
Forgiarini A, Esquena J, González C, Solans C. Formation of nano-emulsions by low energy emulsification methods at constant temperature. Langmuir 2001; 17: 2076-83.
[52]
Porras M, Solans C, González C, Gutiérrez JM. Properties of water-in-oil (W/O) nano-emulsions prepared by a low-energy emulsification method. Colloids Surf A Physicochem Eng Asp 2008; 324(1-3): 181-8.
[53]
Chime SA, Kenechukwu FC, Attama AA. Nanoemulsions -
Advances in formulation, characterization and applications
in drug delivery In: Application of Nanotechnology in
Drug Delivery Sezer AD, Ed London: IntechOpen 2014; pp. 76-126.
[54]
Komaiko JS, McClements DJ. Formation of food-grade nanoemulsions using low-energy preparation methods: A review of available methods. Compr Rev Food Sci Food Saf 2016; 15: 331-52.
[55]
Sengupta P, Chatterjee B. Potential and future scope of nanoemulgel formulation for topical delivery of lipophilic drugs. Int J Pharm 2017; 526(1-2): 353-65.
[56]
Pund S, Rasve G, Borade G. Ex vivo permeation characteristics of venlafaxine through sheep nasal mucosa. Eur J Pharm Sci 2013; 48(1-2): 195-201.
[57]
Schmolka IR. Artificial skin I. Preparation and properties of pluronic F-127 gels for the treatment of burns. J Biomed Mater Res 1972; 6: 571-82.
[58]
Barnes HA. Thixotropy-a review. J Non-Newt Fluid Mech 1997; 70(1-2): 1-33.
[59]
Arora R, Aggarwal G, Harikumar SL, Kaur K. Nanoemulsion based hydrogel for enhanced transdermal delivery of ketoprofen. Adv Pharm 2014; 2014: 1-2.
[60]
Bhura MRG, Bhagat KA, Shah SK. Formulation and evaluation of topical nano emulgel of adapalene World. J Pharm Sci 2015; 3(4): 1013-24.
[61]
Kaur A, Saxena Y, Bansal R, Gupta S, Tyagi A, Sharma RK, et al. Intravaginal delivery of polyphenon 60 and curcumin nanoemulsion gel. AAPS PharmSciTech 2017; 18(6): 2188-202.
[62]
Hosny KM, Banjar ZM. The formulation of a nasal nanoemulsion zaleplon in situ gel for the treatment of insomnia. Expert Opin Drug Deliv 2013; 10(8): 1033-41.
[63]
Elosaily GH. Formulation and in vitro evaluation of nystatin nanoemulsion-based gel for topical delivery. J Am Sci 2012; 2012(8): 541-8.
[64]
Lakshmi P, Kumar GA. Nanosuspension technology: A review. Int J Pharm Pharm Sci 2010; 2(4): 35-40.
[65]
Hasenhuettl GL. Synthesis and commercial preparation of food emulsifiers.In: Food Emulsifiers and Their Applications. 2nd ed. New York: Springer Science Business Media 2008; pp. 11-37.
[66]
Araújo FA, Kelmann RG, Araújo BV, Finatto RB, Teixeira HF, Koester LS. Development and characterization of parenteral nanoemulsions containing thalidomide. Eur J Pharm Sci 2011; 42(3): 238-45.
[67]
Silva HD, Cerqueira MA, Vicente AA. Nanoemulsions for food applications: Development and characterization. Food Bioprocess Technol 2012; 5: 854-67.
[68]
Horne DS. Light scattering studies of colloid stability and gelation.In: New physicochemical techniques for the characterization of complex food systems. London: Blackie Academic & Professional 1995; pp. 240-67.
[69]
Saifullah M, Ahsan A, Shishir MRI. Production, stability and application of micro- and nanoemulsion in food production and food processing industry Emulsions: Nanotechnology in the AgriFood Industry. London: Academic press, Elsevier Inc. 2016; Vol. 3: pp. 405-42.
[70]
Chiesa M, Garg J, Kang YT, Chen G. Thermal conductivity and viscosity of water-in-oil nanoemulsions. Colloids Surf A Physicochem Eng Asp 2008; 326(1-2): 67-72.
[71]
Lakshmana PS, Sharvanan SP, Aravindan S, Bhuvaneswari A, Manikandan V. Nanoemulgel for transdermal delivery of cyclobenzaprine hydrochloride: design, characterization and in vitro studies. Nov Appr Drug Des Dev 2017; 1(5): 555-75.
[72]
Jones DS, Woolfson AD, Brown AF, Coulter WA, McClelland C, Irwin CR. Design, characterisation and preliminary clinical evaluation of a novel mucoadhesive topical formulation containing tetracycline for the treatment of periodontal disease. J Control Release 2000; 67(2-3): 357-68.
[73]
Majithiya RJ, Ghosh PK, Umrethia ML, Murthy RSR. Thermoreversible mucoadhesive gel for nasal delivery of sumatriptan 2006.
[74]
Kumar L, Verma R. In vitro evaluation of topical gel prepared using natural polymer. Int J Drug Deliv 2010; 2: 58-63.
[75]
Kaur G, Bedi PMS, Narang JK. Topical nanoemulgel: a novel pathway for investigating alopecia. J Nanomed Nanotechnol 2017; 8: 472.
[76]
Srdan V. Stankov. Definition of inflammation, causes of inflammation and possible anti-inflammatory strategies. Open Inflamm J 2012; 5: 1-9.
[77]
Dasgupta S, Ghosh SK, Ray S, Kaurav SS, Mazumder B. In vitro & in vivo studies on lornoxicam loaded nanoemulsion gels for topical application. Curr Drug Deliv 2014; 11(1): 132-8.
[78]
Mustafa A, Eid M, Elmarzugi NA, El-Enshasy HA. A review on the phytopharmacological effect of Swietenia macrophylla. Int J Pharm Pharm Sci 2013; 5(Suppl. 3): 47-53.
[79]
Eid AM, El-Enshasy HA, Aziz R, Elmarzugi NA. Preparation, characterization and anti-inflammatory activity of Swietenia macrophylla nanoemulgel. J Nanomed Nanotechnol 2014; 5(2): 190.
[80]
Jaganmohan S. Nanomiemgel - a novel drug delivery system for topical application - in vitro and in vivo evaluation. PLoS One 2014; 9(12)e115952
[81]
Rahman BS, Anwar F, Al-Abbasi FA, Kumar V. Nanotechnology-based nano bullets in anti-psoriatic drug delivery: state of the art nanoscience in dermatology. UK: Elsevier 2016; pp. 157-66.
[82]
Sarfaraz MA, Sajid M, Alam N, Alam MI. Design and characterization of nanostructure topical gel of betamethasone dipropionate for psoriasis. J Appl Pharm Sci 2012; 2(10): 148-58.
[83]
Herrmann ML, Schleyerbach R, Kirschbaum BJ. Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases. Immunopharmacology 2000; 47(2-3): 273-89.
[84]
Kaltwasser JP. Leflunomide in psoriatic arthritis. Autoimmun Rev 2007; 6(8): 511-4.
[85]
Elewski BE, Hay RJ. Update on the management of onychomycosis: highlights of the Third Annual International Summit on Cutaneous Antifungal Therapy. Clin Infect Dis 1996; 23(2): 305-13.
[86]
Mahtab A, Anwar M, Mallick N, Naz Z, Jain GK, Ahmad FJ. Transungual delivery of ketoconazole nanoemulgel for the effective management of onychomycosis. AAPS PharmSciTech 2016; 17(6): 1477-90.
[87]
Elmataeeshy ME, Sokar MS, Bahey-El-Din M, Shaker DS. Enhanced transdermal permeability of Terbinafine through novel nanoemulgel formulation; Development, in vitro and in vivo characterization. Future J Pharm Sci 2018; 4(1): 18-28.
[88]
Aparna C. Enhanced transdermal permeability of telmisartan by a novel nanoemulsion gel. Int J Pharm Pharm Sci 2015; 7(4): 335-42.
[89]
Parhi R, Terapalli BR, Teja BB. Formulation and in vivo evaluation of minoxidil topical gel. Turk J Pharm Sci 2014; 11: 153-62.
[90]
Usmania BA, Kataria MK. Minoxidil emulgel for androgenic alopecia: A literature review including patents. Int J Pharm Drug Anal 2017; 5(3): 49-58.
[91]
Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2002; 47(3): 377-85.
[92]
Rani D, Singh C, Kumar A, Sharma VK. Formulation development and in vitro evaluation of minoxidil bearing glycerosomes. AJBR 2016; 4: 27-37.
[93]
Sunitha S, Wankar J, Ajimera T. Design, Development and evaluation of nanoemulsion and nanogel of itraconazole for transdermal delivery. J Sci Res Pharm 2014; 3(1): 6-11.
[94]
Aithal GC, Nayak UY, Mehta C, Narayan R, Gopalkrishna P, Pandiyan S, et al. Localized in situ nanoemulgel drug delivery system of quercetin for periodontitis: development and computational simulations. Molecules 2018; 23(6): 1363.
[95]
Jeengar MK, Rompicharla SV, Shrivastava S, Chella N, Shastri NR, Naidu VG, et al. Emu oil based nano-emulgel for topical delivery of curcumin. Int J Pharm 2016; 506(1-2): 222-36.
[96]
Mahesh B, Vasanth KP, Gowda DV, Atul S, Raghundan HV, Chetan SG. Enhanced permeability of cyclosporine from a transdermally applied nanoemulgel. Der Pharm Sinica 2015; 6: 69-7.
[97]
Mohammad W, Abdus S, Iram Z, Anubha K, Mohd A, Mohib K. Formulation development Ex-vivo and in-vivo evaluation of nanoemulsion for transdermal delivery of glibenclamide. 2013; 5(Suppl 4): 747-54.
[98]
Singh BP, Kumar B, Jain SK, Shafaat K. Development and characterization of a nanoemulsion gel formulation for transdermal delivery of carvedilol. Int J Drug Dev Res 2012; 4(1): 151-61.
[99]
Drais HK, Hussein AA. Formulation characterization and evaluation of meloxicam nanoemulgel to be used topically. Iraqi J Pharm Sci 2017; 26(1)
[100]
Mulia K, Ramadhan RMA, Krisanti EA. Formulation and characterization of nanoemulgel mangosteen extract in virgin coconut oil for topical formulation. MATEC Web of Conferences 2018; 156: 01013.
[101]
Harwansh RK, Mukherjee PK, Bahadur S, Biswas R. Enhanced permeability of ferulic acid loaded nanoemulsion based gel through skin against UVA mediated oxidative stress. Life Sci 2015; 141: 202-11.
[102]
Pathak MK, Chhabra G, Pathak K. Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex-vivo transcorneal permeation, corneal toxicity and irritation testing. Drug Dev Ind Pharm 2013; 39(5): 780-90.
[103]
Singh KK, Tatke PA, Dhuru S. Neem oil contraceptive
formulations. WO2006082596A2 (2006).
[104]
Novartis AG. Diclofenac in emulsion-gel form
EP2055298A1 (2009).
[105]
Bhushanm RS, Shafiqm S, Jay K, Jitendra P. Stable
pharmaceutical composition of diclofenac.
US20120093882A1 (2012).
[106]
James R. Nanoemulsion containing Composition having
anti- inflammatory activity. WO2008051186A2 (2008).
[107]
Azeem A, Rizwan M, Ahmad FJ, Iqbal Z, Khar RK, Aqil M, et al. Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech 2009; 10(1): 69-76.
,
Subhabrata Ray